<DOC>
	<DOCNO>NCT02714881</DOCNO>
	<brief_summary>The objective study elucidate relationship inflammation lipoprotein atherogenicity , determine relative contribution inflammation lipid CV risk RA . The central hypothesis study inflammation lipoprotein atherogenicity tightly link factor important ass CV risk RA . Further , investigator hypothesize relationship obscured consideration routine lipid alone .</brief_summary>
	<brief_title>Lipids , Inflammation , CV Risk RA</brief_title>
	<detailed_description />
	<mesh_term>Arthritis</mesh_term>
	<mesh_term>Arthritis , Rheumatoid</mesh_term>
	<mesh_term>Inflammation</mesh_term>
	<mesh_term>Cardiovascular Diseases</mesh_term>
	<mesh_term>Certolizumab Pegol</mesh_term>
	<criteria>RA diagnose rheumatologist Fulfills 2010 American College Rheumatology ( ACR ) /European League Against Rheumatism ( EULAR ) Criteria RA Age &gt; 35 Active RA define treat rheumatologist Biologic DMARD naive Patients statin PCSK9 inhibitor therapy Corticosteroid therapy &gt; 10mg prednisone equivalent maintenance treatment Pregnancy Unstable angina ( chest pain ) shortness breath Severe valvular heart disease Myocarditis Pericarditis Asthma active wheezing Cancer treatment within last 5 year Active infectious disease ( HIV , Tuberculosis , Hepatitis B/C )</criteria>
	<gender>All</gender>
	<minimum_age>35 Years</minimum_age>
	<maximum_age>90 Years</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>